Hyperforin prevents β-amyloid neurotoxicity and spatial memory impairments by disaggregation of Alzheimer's amyloid-β-deposits

[1]  Peter Davies,et al.  Resveratrol Promotes Clearance of Alzheimer's Disease Amyloid-β Peptides* , 2005, Journal of Biological Chemistry.

[2]  David Morgan,et al.  Green Tea Epigallocatechin-3-Gallate (EGCG) Modulates Amyloid Precursor Protein Cleavage and Reduces Cerebral Amyloidosis in Alzheimer Transgenic Mice , 2005, The Journal of Neuroscience.

[3]  Xue-jun Li,et al.  Antidepressant effects of curcumin in the forced swim test and olfactory bulbectomy models of depression in rats , 2005, Pharmacology Biochemistry and Behavior.

[4]  N. Inestrosa,et al.  Trolox and 17β-Estradiol Protect against Amyloid β-Peptide Neurotoxicity by a Mechanism That Involves Modulation of the Wnt Signaling Pathway* , 2005, Journal of Biological Chemistry.

[5]  Fusheng Yang,et al.  Curcumin Inhibits Formation of Amyloid β Oligomers and Fibrils, Binds Plaques, and Reduces Amyloid in Vivo* , 2005, Journal of Biological Chemistry.

[6]  V. Papadopoulos,et al.  Ginkgo biloba extract (Egb 761) inhibits beta-amyloid production by lowering free cholesterol levels. , 2004, The Journal of nutritional biochemistry.

[7]  Marcela Colombres,et al.  Structure and function of amyloid in Alzheimer's disease , 2004, Progress in Neurobiology.

[8]  Bruce Blumberg,et al.  Hyperforin, the Active Component of St. John’s Wort, Induces IL-8 Expression in Human Intestinal Epithelial Cells Via a MAPK-Dependent, NF-κB-Independent Pathway , 2004, Journal of Clinical Immunology.

[9]  C. Soto,et al.  β-sheet breaker peptide prevents Aβ-induced spatial memory impairments with partial reduction of amyloid deposits , 2004, Molecular Psychiatry.

[10]  M. Mattson.  Pathways towards and away from Alzheimer's disease , 2004, Nature.

[11]  J. Hartmann,et al.  Stimulation of hippocampal acetylcholine release by hyperforin, a constituent of St. John’s Wort , 2004, Neuroscience Letters.

[12]  S. Montes,et al.  EGb761 Pretreatment Reduces Monoamine Oxidase Activity in Mouse Corpus Striatum During 1-Methyl-4-Phenylpyridinium Neurotoxicity , 2004, Neurochemical Research.

[13]  K. Sasaki,et al.  Ginkgolides, diterpene trilactones of Ginkgo biloba, as antagonists at recombinant α1β2γ2L GABAA receptors , 2004 .

[14]  N. Inestrosa,et al.  Acetylcholinesterase-Aβ Complexes Are More Toxic than Aβ Fibrils in Rat Hippocampus : Effect on Rat β-Amyloid Aggregation, Laminin Expression, Reactive Astrocytosis, and Neuronal Cell Loss , 2004 .

[15]  O. Werz,et al.  Suppression of receptor-mediated Ca2+ mobilization and functional leukocyte responses by hyperforin. , 2004, Biochemical pharmacology.

[16]  S. Fujisawa,et al.  Cytotoxicity, ROS-generation activity and radical-scavenging activity of curcumin and related compounds. , 2004, Anticancer research.

[17]  B. Steiner,et al.  Enhancement of proteolytic processing of the beta-amyloid precursor protein by hyperforin. , 2003, Biochemical pharmacology.

[18]  D. Butterfield.  Amyloid beta-peptide [1-42]-associated free radical-induced oxidative stress and neurodegeneration in Alzheimer's disease brain: mechanisms and consequences. , 2003, Current medicinal chemistry.

[19]  R. Stackman,et al.  Prevention of age-related spatial memory deficits in a transgenic mouse model of Alzheimer's disease by chronic Ginkgo biloba treatment , 2003, Experimental Neurology.

[20]  A. Takashima,et al.  Potent anti‐amyloidogenic and fibril‐destabilizing effects of polyphenols in vitro: implications for the prevention and therapeutics of Alzheimer's disease , 2003, Journal of neurochemistry.

[21]  M. Mattson,et al.  Triple-Transgenic Model of Alzheimer's Disease with Plaques and Tangles Intracellular Aβ and Synaptic Dysfunction , 2003, Neuron.

[22]  Kazuki Sato,et al.  Spherical aggregates of β-amyloid (amylospheroid) show high neurotoxicity and activate tau protein kinase I/glycogen synthase kinase-3β , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[23]  P. Knipschild,et al.  Ginkgo for elderly people with dementia and age-associated memory impairment: a randomized clinical trial. , 2003, Journal of clinical epidemiology.

[24]  N. Inestrosa,et al.  Activation of Wnt signaling rescues neurodegeneration and behavioral impairments induced by β-amyloid fibrils , 2003, Molecular Psychiatry.

[25]  Oliver Werz,et al.  Hyperforin is a dual inhibitor of cyclooxygenase-1 and 5-lipoxygenase. , 2002, Biochemical pharmacology.

[26]  J. Leakey,et al.  Determination of hyperforin in human plasma using solid-phase extraction and high-performance liquid chromatography with ultraviolet detection. , 2002, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[27]  N. Inestrosa,et al.  Laminin affects polymerization, depolymerization and neurotoxicity of Aβ peptide , 2002, Peptides.

[28]  A. Takashima,et al.  Nordihydroguaiaretic acid potently breaks down pre‐formed Alzheimer's β‐amyloid fibrils in vitro , 2002, Journal of neurochemistry.

[29]  W. K. Cullen,et al.  Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo , 2002, Nature.

[30]  Brett Chromy,et al.  Soluble oligomers of β amyloid (1-42) inhibit long-term potentiation but not long-term depression in rat dentate gyrus , 2002, Brain Research.

[31]  M. Baudry,et al.  Attenuation of Staurosporine-Induced Apoptosis, Oxidative Stress, and Mitochondrial Dysfunction by Synthetic Superoxide Dismutase and Catalase Mimetics, in Cultured Cortical Neurons , 2001, Experimental Neurology.

[32]  S. Younkin,et al.  The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Aβ protofibril formation , 2001, Nature Neuroscience.

[33]  P. Marantz,et al.  St John's wort and major depression. , 2001, JAMA.

[34]  R. Tackett,et al.  Effect of St. John's wort on free radical production. , 2001, Life sciences.

[35]  M. Nöldner,et al.  Hypericum extract and hyperforin: memory-enhancing properties in rodents. , 2001, Pharmacopsychiatry.

[36]  D. Selkoe.  Alzheimer's disease: genes, proteins, and therapy. , 2001, Physiological reviews.

[37]  N. Inestrosa,et al.  The role of oxidative stress in the toxicity induced by amyloid β-peptide in Alzheimer’s disease , 2000, Progress in Neurobiology.

[38]  Y. Christen,et al.  The ginkgo biloba extract (EGb 761) protects hippocampal neurons against cell death induced by β‐amyloid , 2000 .

[39]  W. Müller,et al.  Hyperforin, a major antidepressant constituent of St. John's Wort, inhibits serotonin uptake by elevating free intracellular Na+1. , 1999, The Journal of pharmacology and experimental therapeutics.

[40]  Peter T. Lansbury,et al.  Assembly of Aβ Amyloid Protofibrils: An in Vitro Model for a Possible Early Event in Alzheimer's Disease† , 1999 .

[41]  D. Selkoe,et al.  The cell biology of β-amyloid precursor protein and presenilin in Alzheimer's disease , 1998 .

[42]  C. Soto,et al.  Inhibition of Alzheimer β-Fibrillogenesis by Melatonin* , 1998, The Journal of Biological Chemistry.

[43]  D. Walsh,et al.  Amyloid β-Protein Fibrillogenesis , 1997, The Journal of Biological Chemistry.

[44]  M McNamara,et al.  Aggregation and disaggregation of senile plaques in Alzheimer disease. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[45]  B. Solomon,et al.  Disaggregation of Alzheimer β-amyloid by site-directed mAb , 1997 .

[46]  J S Beckman,et al.  Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. , 1996, The American journal of physiology.

[47]  B. Yankner.  Mechanisms of Neuronal Degeneration in Alzheimer's Disease , 1996, Neuron.

[48]  Claudia Linker,et al.  Acetylcholinesterase Accelerates Assembly of Amyloid-β-Peptides into Alzheimer's Fibrils: Possible Role of the Peripheral Site of the Enzyme , 1996, Neuron.

[49]  M. Mattson,et al.  Tumor necrosis factors alpha and beta protect neurons against amyloid beta-peptide toxicity: evidence for involvement of a kappa B-binding factor and attenuation of peroxide and Ca2+ accumulation. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[50]  Brian J Cummings,et al.  Early association of reactive astrocytes with senile plaques in Alzheimer's disease , 1995, Experimental Neurology.

[51]  C. Behl,et al.  Hydrogen peroxide mediates amyloid β protein toxicity , 1994, Cell.

[52]  Brian J Cummings,et al.  Neuritic Involvement within bFGf Immunopositive Plaques of Alzheimer's Disease , 1993, Experimental Neurology.

[53]  H. Levine,et al.  Thioflavine T interaction with synthetic Alzheimer's disease β‐amyloid peptides: Detection of amyloid aggregation in solution , 1993, Protein science : a publication of the Protein Society.

[54]  K. Higuchi,et al.  Kinetic analysis of amyloid fibril polymerization in vitro. , 1991, Laboratory investigation; a journal of technical methods and pathology.

[55]  P. Eikelenboom,et al.  Microglial cells around amyloid plaques in Alzheimer's disease express leucocyte adhesion molecules of the LFA-1 family , 1989, Neuroscience Letters.

[56]  M. Elghetany,et al.  Methods for staining amyloid in tissues: a review. , 1988, Stain technology.

[57]  M. Rizzo,et al.  Blindsight: A case study and implications by L. Weiskrantz, Oxford University Press, 1986. £ 19.50 (viii + 187 pages) ISBN 9 18 852129 4 , 1987, Trends in Neurosciences.

[58]  P. Mcgeer,et al.  Reactive microglia in patients with senile dementia of the Alzheimer type are positive for the histocompatibility glycoprotein HLA-DR , 1987, Neuroscience Letters.

[59]  Sanjiv J. Shah,et al.  Evaluation of anti-inflammatory property of curcumin (diferuloyl methane) in patients with postoperative inflammation. , 1986, International journal of clinical pharmacology, therapy, and toxicology.

[60]  R. Morris.  Developments of a water-maze procedure for studying spatial learning in the rat , 1984, Journal of Neuroscience Methods.

[61]  H. Puchtler,et al.  ON THE BINDING OF CONGO RED BY AMYLOID , 1962 .

[62]  J. Hardy,et al.  The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics , 2009 .

[63]  N. Inestrosa,et al.  Wnt-3a overcomes beta-amyloid toxicity in rat hippocampal neurons. , 2004, Experimental cell research.

[64]  C. Soto,et al.  Beta-sheet breaker peptide prevents Abeta-induced spatial memory impairments with partial reduction of amyloid deposits. , 2004, Molecular psychiatry.

[65]  K. Sasaki,et al.  Ginkgolides, diterpene trilactones of Ginkgo biloba, as antagonists at recombinant alpha1beta2gamma2L GABAA receptors. , 2004, European journal of pharmacology.

[66]  Veronika Butterweck,et al.  Mechanism of Action of St John’s Wort in Depression , 2003, CNS drugs.

[67]  Yuan Luo,et al.  Elevation of oxidative free radicals in Alzheimer's disease models can be attenuated by Ginkgo biloba extract EGb 761. , 2003, Journal of Alzheimer's disease : JAD.

[68]  N. Inestrosa,et al.  Vitamin E but not 17beta-estradiol protects against vascular toxicity induced by beta-amyloid wild type and the Dutch amyloid variant. , 2002, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[69]  P. Butko,et al.  Inhibition of amyloid-beta aggregation and caspase-3 activation by the Ginkgo biloba extract EGb761. , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[70]  Y. Kiuchi,et al.  Type IV collagen prevents amyloid beta-protein fibril formation. , 2002, Life sciences.

[71]  S. Madhusoodanan,et al.  St john's wort and major depression. , 2001, JAMA.

[72]  M. Nybo,et al.  Electron microscopy of prefibrillar structures and amyloid fibrils. , 1999, Methods in enzymology.

[73]  D. Selkoe.  The cell biology of beta-amyloid precursor protein and presenilin in Alzheimer's disease. , 1998, Trends in cell biology.

[74]  C. Soto,et al.  Inhibition of Alzheimer b-Fibrillogenesis by Melatonin* , 1998 .

[75]  B. Solomon,et al.  Disaggregation of Alzheimer beta-amyloid by site-directed mAb. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[76]  D. Salmon,et al.  The Neuropsychology of Alzheimer’s Disease , 1997 .

[77]  N. Inestrosa,et al.  Laminin inhibits amyloid-beta-peptide fibrillation. , 1996, Neuroscience letters.

[78]  P. Fraser,et al.  Alpha 1-antichymotrypsin binding to Alzheimer A beta peptides is sequence specific and induces fibril disaggregation in vitro. , 1993, Journal of neurochemistry.

[79]  G. Paxinos,et al.  The Rat Brain in Stereotaxic Coordinates , 1983 .